4
Changes in Ownership
BOSTON SCIENTIFIC CORP Filed Acc 0001225208-25-001969
EVP and CFO sold 84,863 shares at an average $105.10 ($8,919,296)
- EVP and CFO acquired 60,523 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Brennan Daniel J. · EVP and CFO
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-18 | Sale : show line 1 in the form 10b5-1 | −2,900 | $104.08 | $301,818 | 247,248 | D |
| 2025-02-18 | Sale : show line 2 in the form 10b5-1 | −14,630 | $104.67 | $1,531,366 | 232,618 | D |
| 2025-02-19 | Exercise or conversion : show line 3 in the form 10b5-1 | +18,533 | $24.55 | $454,985 | 251,151 | D |
| 2025-02-19 | Exercise or conversion : show line 4 in the form 10b5-1 | +16,865 | $17.26 | $291,090 | 268,016 | D |
| 2025-02-19 | Exercise or conversion : show line 5 in the form 10b5-1 | +15,642 | $27.09 | $423,742 | 283,658 | D |
| 2025-02-19 | Exercise or conversion : show line 6 in the form 10b5-1 | +9,483 | $40.12 | $380,458 | 293,141 | D |
| 2025-02-19 | Sale : show line 7 in the form 10b5-1 | −67,333 | $105.24 | $7,086,111 | 225,808 | D |
| Open-market sales · 84,863 sh · avg $105.10 · $8,919,296 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-19 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) | −15,642 | 31,285 | D |
| 2025-02-19 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (Right to Buy) | −9,483 | 37,934 | D |
| 2025-02-19 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (Right to Buy) | −16,865 | 0 | D |
| 2025-02-19 | Exercise or conversion : show line 11 in the form 10b5-1 Stock Option (Right to Buy) | −18,533 | 37,067 | D |
Loading xslF345X05/doc4.xml…